TEVA PHARMACEUTICAL INDUSTRIES SPON ADR EACH REP 1 ORD SHS earnings per share and revenue

0LER earnings per share for the last quarter are 0.69 USD whereas the estimation was 0.66 USD which accounts for 4.35% surprise. Company revenue for the same period amounts to 4.33 B USD despite the estimated figure of 4.14 B USD. Estimated earnings per share for the next quarter are 0.69 USD, and revenue is expected to reach 4.10 B USD. Also watch annual changes over time to get a bigger picture of 0LER earnings per share and revenue dynamics.